Publications

  1. Giri K, Shameer K, Zimmermann MT, Saha S, Chakraborty PK, Sharma A, Arvizo RR, Madden BJ, Mccormick DJ, Kocher JP, Bhattacharya R, Mukherjee P. Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem. 2014 Jun 18; 25(6):1078-90. Epub 2014 May 22.
    View PubMed
  2. Arvizo RR, Moyano DF, Saha S, Thompson MA, Bhattacharya R, Rotello VM, Prakash YS, Mukherjee P. Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles. J Biol Chem. 2013 Jun 14; 288(24):17610-8. Epub 2013 Apr 24.
    View PubMed
  3. Arvizo RR, Saha S, Wang E, Robertson JD, Bhattacharya R, Mukherjee P. Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6700-5. Epub 2013 Apr 08.
    View PubMed
  4. Sinha S, Pal K, Elkhanany A, Dutta S, Cao Y, Mondal G, Iyer S, Somasundaram V, Couch FJ, Shridhar V, Bhattacharya R, Mukhopadhyay D, Srinivas P. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer. 2013 Mar 1; 132(5):1201-12. Epub 2012 Jul 27
    View PubMed
  5. Kudgus RA, Szabolcs A, Khan JA, Walden CA, Reid JM, Robertson JD, Bhattacharya R, Mukherjee P. Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. PLoS One. 2013; 8(3):e57522. Epub 2013 Mar 06.
    View PubMed
  6. Mukherjee P, Bhattacharya R, Bone N, Lee YK, Patra CR, Wang S, Lu L, Secreto C, Banerjee PC, Yaszemski MJ, Kay NE, Mukhopadhyay D. Correction: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology. 2013; 11(1):23. Epub 2013 Jul 01.
    View PubMed
  7. Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Basal E, Weaver AL, Visscher DW, Cliby W, Sood AK, Bhattacharya R, Mukherjee P. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One. 2013; 8(11):e79167. Epub 2013 Nov 13.
    View PubMed
  8. Hoeppner LH, Phoenix KN, Clark KJ, Bhattacharya R, Gong X, Sciuto TE, Vohra P, Suresh S, Bhattacharya S, Dvorak AM, Ekker SC, Dvorak HF, Claffey KP, Mukhopadhyay D. Revealing the role of phospholipase Cbeta3 in the regulation of VEGF-induced vascular permeability. Blood. 2012 Sep 13; 120(11):2167-73. Epub 2012 Jun 06.
    View PubMed
  9. Bhattacharya R, Wang E, Dutta SK, Vohra PK, E G, Prakash YS, Mukhopadhyay D. NHERF-2 maintains endothelial homeostasis. Blood. 2012 May 17; 119(20):4798-806. Epub 2012 Feb 17.
    View PubMed
  10. Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev. 2012 Apr 7; 41(7):2943-70. Epub 2012 Mar 05.
    View PubMed
  11. Bhattacharyya S, Singh RD, Pagano R, Robertson JD, Bhattacharya R, Mukherjee P. Switching the targeting pathways of a therapeutic antibody by nanodesign. Angew Chem Int Ed Engl. 2012 Feb 13; 51(7):1563-7. Epub 2011 Dec 01.
    View PubMed
  12. Arvizo RR, Giri K, Moyano D, Miranda OR, Madden B, McCormick DJ, Bhattacharya R, Rotello VM, Kocher JP, Mukherjee P. Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One. 2012; 7(3):e33650. Epub 2012 Mar 19.
    View PubMed
  13. Kudgus RA, Bhattacharya R, Mukherjee P. Cancer nanotechnology: emerging role of gold nanoconjugates. Anticancer Agents Med Chem. 2011 Dec; 11(10):965-73.
    View PubMed
  14. Bhattacharyya S, Khan JA, Curran GL, Robertson JD, Bhattacharya R, Mukherjee P. Efficient delivery of gold nanoparticles by dual receptor targeting. Adv Mater. 2011 Nov 16; 23(43):5034-8. Epub 2011 Oct 04.
    View PubMed
  15. Arvizo RR, Rana S, Miranda OR, Bhattacharya R, Rotello VM, Mukherjee P. Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine. 2011 Oct; 7(5):580-7. Epub 2011 Feb 17.
    View PubMed
  16. Bhattacharyya S, Gonzalez M, Robertson JD, Bhattacharya R, Mukherjee P. A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity. Chem Commun (Camb). 2011 Aug 14; 47(30):8530-2. Epub 2011 Jun 30.
    View PubMed
  17. Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P. Inorganic nanoparticles in cancer therapy. Pharm Res. 2011 Feb; 28(2):237-59. Epub 2010 Nov 23.
    View PubMed
  18. Manickam V, Tiwari A, Jung JJ, Bhattacharya R, Goel A, Mukhopadhyay D, Choudhury A. Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood. 2011 Jan 27; 117(4):1425-35. Epub 2010 Nov 09.
    View PubMed
  19. Wang E, Bhattacharyya S, Szabolcs A, Rodriguez-Aguayo C, Jennings NB, Lopez-Berestein G, Mukherjee P, Sood AK, Bhattacharya R. Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One. 2011; 6(3):e17918. Epub 2011 Mar 21.
    View PubMed
  20. Khan JA, Kudgus RA, Szabolcs A, Dutta S, Wang E, Cao S, Curran GL, Shah V, Curley S, Mukhopadhyay D, Robertson JD, Bhattacharya R, Mukherjee P. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One. 2011; 6(6):e20347. Epub 2011 Jun 27.
    View PubMed
  21. Arvizo RR, Miranda OR, Moyano DF, Walden CA, Giri K, Bhattacharya R, Robertson JD, Rotello VM, Reid JM, Mukherjee P. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One. 2011; 6(9):e24374. Epub 2011 Sep 13.
    View PubMed
  22. Mukherjee P, Katarya A, McMaster N, Gonzalez MA, Bhattacharya R. Synthesis of silver nanocubes by photoreduction of silver salts in the presence of proteins. International Journal of Green Nanotechnology: Biomedicine. 2011; 3(2):134-9.
  23. Patra CR, Jing Y, Xu YH, Bhattacharya R, Mukhopadhyay D, Glockner JF, Wang JP, Mukherjee P. A core-shell nanomaterial with endogenous therapeutic and diagnostic functions. Cancer Nanotechnol. 2010 Dec 1; 1(1):13-8.
    View PubMed
  24. Bhattacharyya S, Bhattacharya R, Curley S, McNiven MA, Mukherjee P. Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci U S A. 2010 Aug 17; 107(33):14541-6. Epub 2010 Aug 02.
    View PubMed
  25. Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, Robertson JD, Rotello VM, Prakash YS, Mukherjee P. Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett. 2010 Jul 14; 10(7):2543-8.
    View PubMed
  26. Verma A, Bhattacharya R, Remadevi I, Li K, Pramanik K, Samant GV, Horswill M, Chun CZ, Zhao B, Wang E, Miao RQ, Mukhopadhyay D, Ramchandran R, Wilkinson GA. Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity. Blood. 2010 Jun 3; 115(22):4614-22. Epub 2010 Jan 19.
    View PubMed
  27. Arvizo R, Bhattacharya R, Mukherjee P. Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv. 2010 Jun; 7(6):753-63.
    View PubMed
  28. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev. 2010 Mar 8; 62(3):346-61. Epub 2009 Nov 13.
    View PubMed
  29. Craig TA, Bhattacharya R, Mukhopadhyay D, Kumar R. Sclerostin binds and regulates the activity of cysteine-rich protein 61. Biochem Biophys Res Commun. 2010 Jan 29; 392(1):36-40. Epub 2009 Dec 31.
    View PubMed
  30. Patra CR, Bhattacharya R, Mukherjee P. Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J Mater Chem. 2010 Jan 1; 20(3):547-54.
    View PubMed
  31. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009 Dec 1; 69(23):9090-5. Epub 2009 Nov 10.
    View PubMed
  32. Sinha S, Vohra PK, Bhattacharya R, Dutta S, Sinha S, Mukhopadhyay D. Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2. J Cell Sci. 2009 Sep 15; 122(Pt 18):3385-92. Epub 2009 Aug 25.
    View PubMed
  33. Bhattacharya R, Kwon J, Li X, Wang E, Patra S, Bida JP, Bajzer Z, Claesson-Welsh L, Mukhopadhyay D. Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci. 2009 Apr 1; 122(Pt 7):1025-34.
    View PubMed
  34. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, Shridhar V, Mukherjee P. Role of hedgehog signaling in ovarian cancer. Clin Cancer Res. 2008 Dec 1; 14(23):7659-66.
    View PubMed
  35. Bhattacharya R, Mukherjee P. Biological properties of "naked" metal nanoparticles. Adv Drug Deliv Rev. 2008 Aug 17; 60(11):1289-306. Epub 2008 Apr 10.
    View PubMed
  36. Patra CR, Bhattacharya R, Wang E, Katarya A, Lau JS, Dutta S, Muders M, Wang S, Buhrow SA, Safgren SL, Yaszemski MJ, Reid JM, Ames MM, Mukherjee P, Mukhopadhyay D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res. 2008 Mar 15; 68(6):1970-8.
    View PubMed
  37. Bhattacharya R, Kwon J, Wang E, Mukherjee P, Mukhopadhyay D. Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J Mol Signal. 2008; 3:8. Epub 2008 Mar 31.
    View PubMed
  38. Bhattacharya R, Sinha S, Yang SP, Patra C, Dutta S, Wang E, Mukhopadhyay D. The neurotransmitter dopamine modulates vascular permeability in the endothelium. J Mol Signal. 2008; 3:14. Epub 2008 Jul 28.
    View PubMed
  39. Patra CR, Bhattacharya R, Patra S, Basu S, Mukherjee P, Mukhopadhyay D. Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research. Clin Chem. 2007 Nov; 53(11):2029-31.
    View PubMed
  40. Mukherjee P, Bhattacharya R, Bone N, Lee YK, Patra CR, Wang S, Lu L, Secreto C, Banerjee PC, Yaszemski MJ, Kay NE, Mukhopadhyay D. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology. 2007; 5:4. Epub 2007 May 08.
    View PubMed
  41. R. Bhattacharya, Chittaranjan Patra, Priyabrata Mukherjee, Debabrata Mukhopadhyay. Assembly of gold nanoparticles in a rod like fashion using biomolecular template ( (3) February, , 319-446). February, 2006; Adv. Func. Materials. Vol:16.
  42. R. Resham Bhattacharya, Mark Bolander, Debabrata Mukhopadhyay, Gobinda Sarkar, Priyabrata Mukherjee. microarray analysis (J Biomed Nanotech Vol1 (4) Dec , 224-228). Dec 2005; Gold nanoparticles do not affect global transcriptional program of human umbilical vein endothelial cells:A DNA.
  43. Bhattacharya R, Kang-Decker N, Hughes DA, Mukherjee P, Shah V, McNiven MA, Mukhopadhyay D. Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling. FASEB J. 2005 Oct; 19(12):1692-4. Epub 2005 Jul 27.
    View PubMed
  44. R. Bhattacharya, Sucharita SenBanerjee, Zhiyong Lin, Samy Mir, Anne Hamik, Ping Wang, D. Mukhopadhyay and Mukesh K Jain Inhibition of VPF/VEGF-mediated angiogenesis by the Kruppel-like factor KLF2 (J Biol Chem 280 (). 2005 Aug 12; 32):28848-51.
  45. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 2005 May 1; 11(9):3530-4.
    View PubMed
  46. Mukherjee P, Bhattacharya R, Mukhopadhyay D. Gold nanoparticles bearing functional anti-cancer drug and anti-angiogenic agent: A “ 2 in 1” system with potential application in cancer therapeutics. J Biomed Nanotech. 2005; 2:224.
  47. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy J, Atala A, Mukhopadhyay D, Soker S. Anti Angiogenic Property of Gold Nanoparticles. (Clinical Cancer Research 11 (9). 2005; 3530-3534).
  48. Bhattacharya R, Mukherjee P, Xiong Z, Atala A, Soker S, Mukhopadhyay D. Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells. Nano lett. 2004 Dec; 4(12):2479-81.
  49. Zeng H, Bhattacharya R, Mukhopadhyay D. Complexity in VPF/VEGF receptors signaling. (Mol Cell Biochem , 264 (1-2),. 2004; 51-61).
  50. Datta K, Li J, Bhattacharya R, Gasparian L, Wang E, Mukhopadhyay D. Role of PKC zeta in regulation of HIF 2 alpha by promoting its association with p300 in renal cancer. (Cancer Research 64, Jan ,. Jan 2003; 456-462).
  51. Bhattacharya R, Beck DJ. The role of the RecFOR, RecBCD pathways and the polB gene in survival and induction of the SOS response in E. coli (DNA Repair ( , 1 (11), 955-966). 2002, 1; Amst).